Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.13 USD | +4.63% | +6.60% | +30.64% |
Business Summary
Number of employees: 325
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Drugs
100.0
%
| 157 | 100.0 % | 146 | 100.0 % | -7.03% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 157 | 100.0 % | 146 | 100.0 % | -7.03% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Richard Paulson
CEO | Chief Executive Officer | 56 | 25/02/20 |
Mike Mason
DFI | Director of Finance/CFO | 49 | 24/02/19 |
Amama Sadiq
CTO | Chief Tech/Sci/R&D Officer | - | 31/03/23 |
Accumanno James
CMP | Compliance Officer | - | 30/04/21 |
Reshma Rangwala
CTO | Chief Tech/Sci/R&D Officer | 46 | 31/03/22 |
Elhan Webb
IRC | Investor Relations Contact | - | 13/03/22 |
Lisa DiPaolo
HRO | Human Resources Officer | - | 31/08/22 |
Stuart Poulton
PRN | Corporate Officer/Principal | 51 | 31/01/22 |
Sohanya Cheng
PRN | Corporate Officer/Principal | 41 | 07/06/21 |
Michael Mano
LAW | General Counsel | 47 | 14/12/20 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Garen Bohlin
BRD | Director/Board Member | 76 | 02/10/13 |
Barry Greene
BRD | Director/Board Member | 60 | 31/12/12 |
Director/Board Member | 59 | 31/03/13 | |
Chen Schor
BRD | Director/Board Member | 51 | 24/11/20 |
Mansoor Mirza
BRD | Director/Board Member | 63 | 30/09/10 |
Richard Paulson
CEO | Chief Executive Officer | 56 | 25/02/20 |
Christy Oliger
BRD | Director/Board Member | 54 | 27/08/20 |
Su Zhen
BRD | Director/Board Member | 47 | 30/08/23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 116,465,736 | 111,325,311 ( 95.59 %) | 0 | 95.59 % |
Company contact information
Karyopharm Therapeutics, Inc.
85 Wells Avenue Suite 210, 2nd floor
02459-3298, Newton
+617 658 0600
http://www.karyopharm.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+30.64% | 126M | |
-1.43% | 103B | |
+8.96% | 101B | |
+4.40% | 23.07B | |
-12.15% | 22.23B | |
-4.36% | 18.05B | |
-39.98% | 17.18B | |
-10.04% | 16.94B | |
+6.79% | 14.07B | |
+38.61% | 12.35B |
- Stock Market
- Equities
- KPTI Stock
- Company Karyopharm Therapeutics Inc.